News & Updates

Show Multimedia Only

CD19 CAR T cell therapy improves QOL, cuts healthcare costs in SLE

Quality of life (QOL) among patients with systemic lupus erythematosus (SLE) improves following CD19 chimeric antigen receptor (CAR) T cell therapy, with also helps lessen the socioeconomic burden associated with active disease, a study has shown.

CD19 CAR T cell therapy improves QOL, cuts healthcare costs in SLE

Just Now

Meta-analysis supports CAZ/AVI as Tx option for OXA-48–producing CRE

1 hour ago by

A systematic review and meta-analysis conducted by researchers in Singapore support ceftazidime-avibactam (CAZ/AVI) as a primary therapeutic alternative for the treatment of OXA-48–producing carbapenem-resistant Enterobacterales (CRE).

Meta-analysis supports CAZ/AVI as Tx option for OXA-48–producing CRE

1 hour ago

Lead exposure may put children at risk of depression

5 hours ago

Low-levels blood lead concentrations in children are associated with the presence of depressive symptoms in later childhood, according to a study.

Lead exposure may put children at risk of depression

5 hours ago

Nortriptyline misses mark in functional dyspepsia trial

17 hours ago

The tricyclic antidepressant nortriptyline is only as good as placebo in terms of reducing symptoms of functional dyspepsia in preselected patients, according to the results of a multicentre randomized controlled trial.

Nortriptyline misses mark in functional dyspepsia trial

17 hours ago

Low SBP does not raise risk of all-cause mortality, CV events

23 hours ago

Blood pressure (BP) shows a linear association with several cardiovascular (CV) and renal outcomes in patients with type 2 diabetes (T2D), reveals a study.

Low SBP does not raise risk of all-cause mortality, CV events

23 hours ago

PFS gains seen with savolitinib–osimertinib combo in EGFR-mutant, MET-amplified NSCLC

a day ago

Treatment with the combination of savolitinib plus osimertinib prolongs progression-free survival (PFS) in patients with non-small cell lung cancer (NSCLC) harbouring EGFR mutation and MET amplification, as shown in the phase III SACHI trial.

PFS gains seen with savolitinib–osimertinib combo in EGFR-mutant, MET-amplified NSCLC

a day ago

Age, rehabilitation timing factor in functional outcomes in stroke survivors

a day ago by

Older age and early initiation of rehabilitation predict functional improvement in patients undergoing stroke rehabilitation within Singapore’s community hospital setting, according to local research.

Age, rehabilitation timing factor in functional outcomes in stroke survivors

a day ago

CAD incidence lower in HCM vs non-HCM patients

07 Feb 2026

Patients with hypertrophic cardiomyopathy (HCM) undergoing computed tomography angiography (CTA) for table chest pain enjoy a lower incidence of obstructive coronary artery disease (CAD) and show more stable coronary plaque features than those with no HCM, reveals a study.

CAD incidence lower in HCM vs non-HCM patients

07 Feb 2026

Delayed puberty in males a red flag for T2D risk

07 Feb 2026

Male teens with delayed puberty have an increased likelihood of developing type 2 diabetes (T2D) in early adulthood, regardless of BMI, according to a retrospective study.

Delayed puberty in males a red flag for T2D risk

07 Feb 2026

GLP-1RA bests aspirin for CRC prevention

06 Feb 2026 by

Use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) appears to confer greater protection against the development of colorectal cancer (CRC) as compared with aspirin, according to a retrospective study.

GLP-1RA bests aspirin for CRC prevention

06 Feb 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

CD19 CAR T cell therapy improves QOL, cuts healthcare costs in SLE

CD19 CAR T cell therapy improves QOL, cuts healthcare costs in SLE

Meta-analysis supports CAZ/AVI as Tx option for OXA-48–producing CRE

Meta-analysis supports CAZ/AVI as Tx option for OXA-48–producing CRE

Lead exposure may put children at risk of depression

Lead exposure may put children at risk of depression

Nortriptyline misses mark in functional dyspepsia trial

Nortriptyline misses mark in functional dyspepsia trial

Low SBP does not raise risk of all-cause mortality, CV events

Low SBP does not raise risk of all-cause mortality, CV events

PFS gains seen with savolitinib–osimertinib combo in EGFR-mutant, MET-amplified NSCLC

PFS gains seen with savolitinib–osimertinib combo in EGFR-mutant, MET-amplified NSCLC

Age, rehabilitation timing factor in functional outcomes in stroke survivors

Age, rehabilitation timing factor in functional outcomes in stroke survivors

CAD incidence lower in HCM vs non-HCM patients

CAD incidence lower in HCM vs non-HCM patients

Delayed puberty in males a red flag for T2D risk

Delayed puberty in males a red flag for T2D risk

GLP-1RA bests aspirin for CRC prevention

GLP-1RA bests aspirin for CRC prevention